Does Increasing the Compression Pause From 3 to 5 Seconds in Mechanical Compression Devices Increase Ventilation Success Rate and Return of Spontaneous Circulation?
LUCASVP
1 other identifier
interventional
692
1 country
2
Brief Summary
To give chest compressions during cardiopulmonary resuscitation (CPR), mechanical chest compression devices can be used. During synchronous 30:2 CPR, the standard setting on these devices leave an automated 3-second chest compression pause after 30 compressions to facilitate caregivers in providing two ventilations. With this standard setting, research has shown that in less than half of ventilation pauses during CPR, those two ventilations are given. Increasing the ventilation pause duration to 5 seconds instead of 3 seconds is also an option following current guideline recommendations, and aligns with measured ventilation pause duration in manual CPR. Increasing pause duration to 5 seconds could result in an increased ventilation success rate. This multicenter randomized controlled trial will randomize LUCAS® mechanical compression devices to a standard setting of 3- or 5-second compression pauses. The main outcome will be the percentage of ventilation pauses in which two ventilations are successfully given. Secondary outcomes include the restoration of spontaneous circulation (ROSC), and the difference in (neurologically intact) survival. No study has been performed to evaluate this effect yet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2025
CompletedFirst Posted
Study publicly available on registry
February 13, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
February 13, 2025
January 1, 2025
1.5 years
January 21, 2025
February 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of ventilation pauses in which two ventilations are given
The difference in percentage of ventilation pauses in which two ventilations are given between the intervention and control group
From enrollment to end of mechanically assisted CPR by ambulance nurses (approximate maximum timeframe of 3 hours)
Secondary Outcomes (12)
Return of spontaneous circulation (ROSC)
From enrollment to end of cardiac arrest treatment (approximate maximum timeframe of 5 hours)
Cerebral performance score (CPC score) at hospital discharge (CPC 1-2 vs. 3-4)
From enrollment to hospital discharge (approximate maximum timeframe of 3 months)
Survival to hospital discharge
From enrollment to hospital discharge (approximate maximum timeframe of 3 months)
30-day survival
From enrollment to 30 days after cardiac arrest
Number of rhythm checks per five minutes, expected
From enrollment to prehospital termination of CPR or handover at hospital by ambulance nurses (approximate maximum timeframe of 3 hours)
- +7 more secondary outcomes
Study Arms (2)
Intervention - 5-second ventilation pause
EXPERIMENTALPatients in this group will have ventilation pauses lasting 5 seconds in between cardiac compressions given by mechanical CPR
Control - 3-second ventilation pauses
ACTIVE COMPARATORPatients in this group will have ventilation pauses lasting the standard 3 seconds in between cardiac compressions given by mechanical CPR
Interventions
The intervention is a 5-second lasting ventilation pause during mechanical CPR
The intervention is a 3-second lasting ventilation pause during mechanical CPR
Eligibility Criteria
You may qualify if:
- Adults (≥16 years of age)
- OHCA patients with an attempt at cardiopulmonary resuscitation (CPR) by ambulance personnel
- LUCAS® 3.1 has been used during the resuscitation attempt
You may not qualify if:
- Missing ambulance run report, missing or unclear impedance signal (measurement of resistance across the thorax), making it impossible to assess the number of ventilation pauses
- Absence of a minimum of 3 assessable pauses intended for ventilation after connecting the LUCAS®
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ambulance Amsterdam
Amsterdam, North Holland, 1075LB, Netherlands
Regionale Ambulance Voorziening Kennemerland - Ambulancezorg GGD Kennemerland
Haarlem, North Holland, 2015CK, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Schober, MD, PhD
Amsterdam UMC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator: Professor Emergency Medicine in Anesthesiology Dr. Patrick Schober, MD, PhD.
Study Record Dates
First Submitted
January 21, 2025
First Posted
February 13, 2025
Study Start
March 1, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
April 1, 2027
Last Updated
February 13, 2025
Record last verified: 2025-01